CDC
WASHINGTON - CDC has confirmed the influenza neuraminidase N1 subtype of the U.S. case of human avian influenza A(H5) reported last week by genetic sequencing. Genetic characterization is ongoing and final data will be made publicly available in GenBankexternal icon as soon as available.
Background. A person has tested positive for avian influenza A(H5) virus (H5 bird flu) in the U.S., as reported by Colorado and confirmed by CDC. This case occurred in a person who had direct exposure to poultry and was involved in the culling (depopulating) of poultry with presumptive H5N1 bird flu. The patient reported fatigue for a few days as their only symptom and has since recovered. The patient is being isolated and treated with the influenza antiviral drug oseltamivir.
Click here to learn more.
Source: CDC.gov
Get curated news on YOUR industry.
Enter your email to receive our newsletters.
Latest from Quality Assurance & Food Safety
- Q&A: Sandra Eskin Leads Food Safety Advocacy Organization, STOP, as CEO
- STOP CEO Eskin on Government Layoffs, Challenges in Food Safety
- Mission Barns Announces Cell-Cultivated Pork Fat Launch Following FDA Clearance
- Hearthside Food Solutions Recalls Breakfast Sandwiches Due to Undeclared Allergen
- Walker’s Wine Juice Recalls Pumpkin Juice Due to Botulism Risk
- The Cascading Food Safety Impacts of Tariffs on the Food Industry
- Tyson Ventures Calls Startups to Apply for Tyson Demo Day
- Student Finalists Selected for IFT Product Development Competitions
